Chakrabhavi Dhananjaya Mohan Selected Research

Chakrabhavi Dhananjaya Mohan Research Topics

Disease

24	Neoplasms (Cancer) 11/2022 - 12/2014
11	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2014
6	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2015
6	Carcinogenesis 01/2022 - 02/2015
4	Neoplasm Metastasis (Metastasis) 06/2021 - 02/2015
4	Carcinoma (Carcinomatosis) 09/2019 - 06/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 10/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 12/2019
2	Malaria 01/2022 - 01/2016
2	Lung Neoplasms (Lung Cancer) 09/2020 - 09/2019
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017 - 01/2016
1	Toxoplasmosis 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Leukemia 01/2022
1	Multiple Myeloma 10/2021
1	COVID-19 06/2021
1	Colitis 06/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2021
1	Fibrosis (Cirrhosis) 06/2021
1	Pancreatitis 06/2021
1	Virus Diseases (Viral Diseases) 06/2021
1	Sarcoma (Soft Tissue Sarcoma) 05/2019
1	Hematologic Neoplasms (Hematological Malignancy) 05/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Triple Negative Breast Neoplasms 12/2016
1	Inflammation (Inflammations) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Parasitic Diseases (Parasitic Disease) 09/2015

Drug/Important Bio-Agent (IBA)

8	Transcription Factors (Transcription Factor)IBA 11/2021 - 12/2014
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2015
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2021 - 12/2014
4	Biological ProductsIBA 11/2020 - 12/2014
3	Antineoplastic Agents (Antineoplastics)IBA 11/2022 - 01/2016
3	Pharmaceutical PreparationsIBA 11/2022 - 09/2015
3	heparanaseIBA 06/2021 - 01/2017
3	Caspase 3 (Caspase-3)IBA 01/2019 - 12/2014
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2021
2	Proteoglycans (Proteoglycan)IBA 06/2021 - 01/2017
2	Glycoside Hydrolases (Endoglycosidases)IBA 06/2021 - 01/2017
2	Heparin (Liquaemin)FDA LinkGeneric 06/2021 - 05/2019
2	Heparitin Sulfate (Heparan Sulfate)IBA 06/2021 - 01/2017
2	brusatolIBA 11/2020 - 01/2019
2	1,3,4-oxadiazoleIBA 09/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 12/2019 - 01/2016
2	OxazinesIBA 01/2017 - 01/2016
2	azaspiraneIBA 09/2016 - 12/2014
2	Estrogen ReceptorsIBA 09/2016 - 04/2015
2	LigandsIBA 09/2015 - 04/2015
1	CateninsIBA 06/2022
1	euphorbiasteroidIBA 06/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022
1	TriterpenesIBA 01/2022
1	Thymidine PhosphorylaseIBA 01/2022
1	Antiparasitic Agents (Antiparasitics)IBA 01/2022
1	Pyrimethamine (Daraprim)FDA Link 01/2022
1	dehydroabietylamineIBA 01/2022
1	trans-sodium crocetinate (crocetin)IBA 11/2021
1	tris(dibenzylideneacetone)dipalladiumIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	ThiadiazolesIBA 06/2021
1	Neutralizing AntibodiesIBA 06/2021
1	Phenol (Carbolic Acid)FDA Link 06/2021
1	ChemokinesIBA 03/2021
1	Mitogen-Activated Protein KinasesIBA 03/2021
1	QuassinsIBA 03/2021
1	OccludinIBA 11/2020
1	Cadherins (E-Cadherin)IBA 11/2020
1	IndazolesIBA 09/2020
1	OxadiazolesIBA 09/2020
1	matrigelIBA 08/2020
1	vitexinIBA 08/2020
1	CyclohexaneIBA 09/2019
1	EnzymesIBA 09/2019
1	Adenosine Monophosphate (AMP)IBA 09/2019
1	TriazolesIBA 09/2019
1	pyridineIBA 09/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 09/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Annexin A5IBA 01/2019
1	4-nitrophenethyl bromide (NPB)IBA 10/2018
1	N-cyclopentyl-3-((4-(2,3-dichlorophenyl) piperazin-1-yl) (2-hydroxyphenyl) methyl) benzamideIBA 10/2018
1	Apoptosis Regulatory ProteinsIBA 10/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	PyrimidinesIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 12/2016
1	PyrazolesIBA 12/2016
1	undecaneIBA 09/2016
1	diphenyl (biphenyl)IBA 02/2016
1	SodiumIBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Dextrans (Dextran)FDA Link 01/2016
1	ImidazolesIBA 01/2016
1	PhthalazinesIBA 01/2016
1	Ionic LiquidsIBA 01/2016
1	compound 21IBA 09/2015
1	quinolineIBA 09/2015

Therapy/Procedure

5	Therapeutics 11/2022 - 12/2014
1	Immunotherapy 11/2022